Pfizer asks US officials to OK promising COVID-19 pill
Summary by STAT
Pfizer CEO Albert Bourla said the company will ask the FDA on Tuesday to authorize emergency use of its antiviral pill to combat Covid-19.
0 Articles
0 Articles
All
Left
Center
Right
Yahoo News
Pfizer asks US officials to OK promising COVID-19 pill
Pfizer said Tuesday it is asking U.S. regulators to authorize its experimental pill for COVID-19, setting the stage for a likely launch of the promising therapy in the coming weeks. It is one of a handful of pills that have recently been shown to significantly cut hospitalizations and deaths among people infected with COVID-19. If authorized by the Food and Drug Administration it could be a major step toward managing the pandemic and returning…
Pfizer asks US officials to OK promising COVID-19 pill
Pfizer is submitting its experimental pill for COVID-19 for U.S. authorization, setting the stage for a likely launch of the promising therapy in coming weeks
Pfizer files for U.S. authorization of COVID-19 pill
By Michael Erman - Pfizer Inc said on Tuesday it is seeking U.S. authorization of its experimental antiviral COVID-19 pill that cut the chance of hospitalization or death for adults at risk of severe disease by 89% in a clinical trial. Pfizer said it completed submission of its application for emergency use authorization (EUA) of the drug, Paxlovid, with the U.S. Food and Drug
Pfizer asks US officials to OK promising COVID-19 pill
WASHINGTON (AP) — Pfizer said Tuesday it is asking U.S. regulators to authorize its experimental pill for COVID-19, setting the stage for a likely launch of the promising therapy in the coming weeks.
Pfizer asks US officials to OK promising COVID-19 pill
Pfizer is submitting its experimental pill for COVID-19 for U.S. authorization, setting the stage for a likely launch of the promising therapy in coming weeks
Pfizer seeks FDA emergency use authorization for its experimental Covid-19 antiviral pill
Pfizer announced Tuesday that it is seeking emergency use authorization from the US Food and Drug Administration for its experimental antiviral Covid-19 pill, known as PF-07321332 or Paxlovid.